Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

EU Clinical Trials Register is Launched

March 29, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has announced the launch of its EU Clinical Trials Register. This online register allows public …
News
Press release

Chiltern Expands European Operations with a New Office in The Netherlands

March 29, 2011 Research and Development

Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in …
News
Press release

Telaprevir to be added to standard hep C therapy

March 27, 2011 Research and Development, Sales and Marketing hepatitis C, telaprevir

Telaprevir – currently being co-developed by Vertex, Johnson & Johnson and Mitsubishi Tanabe  – will become part of a standard …
News

GSK withdraws applications for Avodart

March 25, 2011 Research and Development Avodart, Cancer, GSK, bph, prostate cancer

GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …
News
Sanofi-Aventis headquarters

Sanofi signs ophthalmology research collaboration

March 25, 2011 Research and Development Fovea, Sanofi-Aventis, Vision Institute, ophthalmology

Sanofi-Aventis has penned a collaboration with one of the main eye disease research centres in Europe. The three-year agreement between …
News

Cephalon buys Gemin X for $225 million

March 24, 2011 Research and Development Cephalon, lung cancer

Cephalon is to acquire oncology specialist Gemin X and gain access to its cancer candidate obatoclax. The US biopharmaceutical firm …
News
aquapharm_bertrand_lehuu

Bertrand Lehuu joins Aquapharm

March 24, 2011 Research and Development appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …
Appointment

Budget provides UK science incentives

March 24, 2011 Research and Development George Osborne, R&D tax credits, clinical trials

Chancellor George Osborne has unveiled tax incentives, new funding and moves to cut red tape for the life sciences sector …
News
GlaxoSmithKline office

GSK to fund schools science programme

March 23, 2011 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science

GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …
News

BMS skin cancer vaccine hits phase III target

March 23, 2011 Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab

Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …
News
Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011 Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …
News

GSK Parkinson’s drug impresses at phase III

March 21, 2011 Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …
News
Obesity

Takeda obesity drug falters at phase II

March 18, 2011 Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide

Yet another investigational drug appears to have faltered on the rocky path to develop anti-obesity treatments. Takeda Pharmaceutical Company and …
News
efpia_lif_richard_bergstrom

Richard Bergström takes DG role at EFPIA

March 18, 2011 Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing

European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …
Appointment

Biotech lobbies for further UK tax breaks

March 17, 2011 Research and Development BIA, R&D tax credits, biotech

Biotech companies are calling on Chancellor George Osborne to provide extra incentives for research in his forthcoming Budget. The budget …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026